Daniel Bernstein
Publication Details
-
Efficacy and safety of atorvastatin after pediatric heart transplantation.
J Heart Lung Transplant. 2002; (11): 1213-7
Lipid abnormalities are prevalent after pediatric and adult heart transplantation. 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are efficacious and safe and can lower the incidence of graft coronary artery disease after heart transplantation in adults. Given the high prevalence of lipid abnormalities and the increased recognition of graft coronary disease in children, we retrospectively investigated the efficacy and safety of atorvastatin among pediatric heart transplant recipients.
Help
Trial Administration